Stanley Lapidus Net Worth & Insider Trades
Stanley Lapidus - Director, T2 Biosystems, Inc
What is Stanley Lapidus's Net Worth?
The current estimated net worth of T2 Biosystems, Inc's Director, Stanley Lapidus, is estimated to be about $1.01M . Stanley Lapidus owns about 53,010 units of T2 Biosystems, Inc common stock. In the last 4 years at T2 Biosystems, Inc, Stanley Lapidus has sold an estimated value of $98.17K worth.
What is Stanley Lapidus's Past Insider Trading?
Stanley Lapidus's largest purchase order was 27,058 units , worth over $31.39K on November 8, 2018. Stanley Lapidus's largest sale order was 6,000 units , worth over $53.22K on June 5, 2018. In total, Stanley Lapidus has made about 9 transactions over 4 years of their time at T2 Biosystems, Inc. Stanley Lapidus usually trades in June, with the busiest year in 2018. The most recent transaction was a sale order of 9,000 units , worth over $12.96K on June 13, 2019.
STANLEY LAPIDUS
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Stanley Lapidus's' Mailing Address?
- Mailing address is C/o Exact Sciences Corp 63 Great Rd Maynard MA 01754 MA
T2 Biosystems, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John Sperzel, | 2020 | $490,705 | - | - | $2,571,384 | $393,750 | $3,000 | $3,458,839 |
| John McDonough, | 2020 | $72,906 | - | $74,999 | - | - | $1,022,182 | $1,170,087 |
| John McDonough, | 2019 | $550,000 | - | $372,000 | $478,728 | $233,750 | $3,000 | $1,637,478 |
| Alec Barclay, | 2020 | $340,000 | - | $25,675 | $38,621 | $234,600 | $952 | $639,848 |
| Alec Barclay, | 2019 | $337,500 | $35,000 | $111,600 | $348,834 | $102,000 | $2,900 | $937,834 |
| Anthony Pare, | 2020 | $325,000 | - | $20,738 | $159,763 | $185,250 | $3,000 | $693,751 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm
What are T2 Biosystems, Inc's Past Insider Trades?
T2 Biosystems, Inc's most recent insider trade came on November 22, 2022 by Brett Giffin who sold 1,292 units worth $2.32K . In the last 8 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.08M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer, David Elsbree, Director, and Terrence Michael Gibbs, General Counsel .
T2 Biosystems, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||